IA
ARMP icon

IFP Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

IFP Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$7K Hold
1,679
– – ﹤0.01% 1745
2018
Q4 		$5K Hold
1,679
– – ﹤0.01% 2814
2018
Q3 		$24K Hold
1,679
– – ﹤0.01% 2352
2018
Q2 		$27K Buy
+1,679
New +$27.3K ﹤0.01% 2283
2016
Q2 		– Sell
-168
Closed -$7K – 3830
2016
Q1 		$7K Buy
+168
New +$86.1K ﹤0.01% 1745

Other funds holding ARMP

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SXL
Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return

IFP Advisors's ARMP Position: Q1 2019 in Review

IFP Advisors held its Armata Pharmaceuticals (ARMP) position steady in Q1 2019 at 1,679 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1745.

IFP Advisors first reported a position in ARMP in Q1 2016 and has held it in 5 quarters since. The position peaked at $27K in Q2 2018. 25 funds tracked by Wall St. Rank hold ARMP as of Q1 2019.

  • IFP Advisors held 1,679 shares of Armata Pharmaceuticals worth $7K as of Q1 2019.
  • IFP Advisors left its Armata Pharmaceuticals share count unchanged in Q1 2019.
  • Armata Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q1 2019, its #1745 holding.
  • IFP Advisors first reported a position in Armata Pharmaceuticals in Q1 2016 and has held it in 5 quarters since.
  • IFP Advisors's Armata Pharmaceuticals position peaked at $27K in Q2 2018.
  • 25 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.